Inhibrx holder files Rule 144 to sell 500 shares

Inhibrx Biosciences, Inc. (INBX) is the issuer for which a notice has been filed to permit the potential resale of its common stock under Rule 144 on behalf of Kimberly Manhard.

Rhea-AI Filing Summary

Inhibrx Biosciences, Inc. (INBX) is the issuer for which a notice has been filed to permit the potential resale of its common stock under Rule 144 on behalf of Kimberly Manhard. The notice covers 500 shares of common stock held in the Kimberly Joan Manhard Revocable Trust. The filing lists an aggregate market value of $57,570.00 for these shares and identifies Fidelity Brokerage Services LLC as the broker, with the notice dated September 8, 2026.

Key Figures

Shares covered by Rule 144 notice: 500 shares Aggregate market value of shares: $57,570.00 Date of Notice: September 8, 2026 +2 more

5 metrics

Shares covered by Rule 144 notice 500 shares Common stock of Inhibrx Biosciences, Inc. referenced in the Form 144

Aggregate market value of shares $57,570.00 Value associated with the 500 INBX common shares in the securities information table

Date of Notice September 8, 2026 Date on which the Rule 144 notice for INBX was filed

Shares listed in Securities To Be Sold section 500 shares Common stock acquired via open market purchase on August 28, 2024

Acquisition date of securities August 28, 2024 Date of open market purchase shown in the Securities To Be Sold section

Key Terms

Rule 144, Open Market Purchase, attorney-in-fact, Form 144

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Open Market Purchase financial

"Common | 08/28/2024 | Open Market Purchase | Issuer"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

attorney-in-fact regulatory

"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kimberly Manhard."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does the Form 144 filed for INBX disclose about planned share sales?

The Form 144 for Inhibrx Biosciences, Inc. (INBX) reports a planned potential resale of 500 shares of common stock under Rule 144, with an aggregate market value of $57,570.00, held for the account of Kimberly Manhard through a revocable trust.

Who is the selling security holder in the INBX Form 144 filing?

The selling security holder is Kimberly Manhard, with the shares referenced as being held in the Kimberly Joan Manhard Revoc Tr, where she is a trustee. The filing is submitted on her behalf for potential sales under Rule 144.

How many INBX shares are covered by this Form 144 notice?

The notice covers 500 shares of Inhibrx Biosciences, Inc. common stock. These shares are listed in the securities information section and are the amount referenced as potentially to be sold under Rule 144 through Fidelity Brokerage Services LLC.

What is the aggregate market value of the INBX shares in this Form 144?

The Form 144 lists an aggregate market value of $57,570.00 for the 500 shares of Inhibrx Biosciences, Inc. common stock covered by the notice. This value appears in the securities information table associated with the proposed Rule 144 sale.

Which broker is involved in the INBX Form 144 transaction?

The broker listed is Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. The Form 144 is signed by Joshua Schmitt as a duly authorized representative of Fidelity, acting as attorney-in-fact for Kimberly Manhard.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 07:59 PM Accepted by SEC EDGAR 09/08/2026 - 07:59 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001202094
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Inhibrx Biosciences, Inc.
SEC File Number	001-42031
Address of Issuer	11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CALIFORNIA 92037
Phone	(858) 795-4220
Name of Person for Whose Account the Securities are To Be Sold	MANHARD KIMBERLY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	500	57570.00	14717660	09/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/28/2024	Open Market Purchase	Issuer			500	08/28/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Today's sale occurred in the Kimberly Joan Manhard Revoc Tr of which Kimberly Manhard is a trustee.
Date of Notice	09/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kimberly Manhard.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)